Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Transposon Therapeutics, Inc. See All Filings	D	2024-07-15 16:27:57 UTC
Amount To Be Raised $20,000,000 Associated Brokers / Dealers N/A CIK Number 0001810705 Filed Document 0001810705-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-07-15 16:27:57 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Debt
Transposon Therapeutics, Inc. See All Filings	D/A	2023-01-12 12:43:58 UTC
Amount To Be Raised $20,020,000 Associated Brokers / Dealers N/A CIK Number 0001810705 Filed Document 0001810705-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-01-12 12:43:58 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Transposon Therapeutics, Inc. See All Filings	D	2022-12-29 13:07:14 UTC
Amount To Be Raised $20,020,000 Associated Brokers / Dealers N/A CIK Number 0001810705 Filed Document 0001810705-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-12-29 13:07:14 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Transposon Therapeutics, Inc. See All Filings	D	2020-12-09 15:47:06 UTC
Amount To Be Raised $45,187,328 Associated Brokers / Dealers N/A CIK Number 0001810705 Filed Document 0001810705-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-12-09 15:47:06 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Transposon Therapeutics, Inc. See All Filings	D	2020-05-06 17:11:15 UTC
Amount To Be Raised $6,500,000 Associated Brokers / Dealers N/A CIK Number 0001810705 Filed Document 0001382963-20-000086 Exclusions or Exemptions 506b Accepted Date 2020-05-06 17:11:15 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity